Biomarkers used to detect the presence of a disease or condition and to identify individuals with subtype of disease. Diagnostic Biomarkers allows the development of screening programs of certain cancers (cellular and molecular pathology). Therapeutic biomarkers has involved in huge therapeutic range in treating cardiovascular, rare diseases, infectious diseases, inherited diseases.
Related Conferences: International Conference on Molecular Biology and Stem Cells, November 19-20, 2018 at Paris, France; 12th International Conference on Cancer Stem Cells and Oncology Research, March 15-17, 2019 at Rome, Italy; 9th European Congress on Breast Cancer, Women’s health and Therapeutics, February 25-27, 2019; 2nd World Congress on Stem Cells and Regenerative Medicine, March 14-15, 2019, London, UK
Related Associations: The Biomarkers consortium, International Society for Oncology and Biomarkers, Biomarkers profile corporation, World Molecular Imaging Society, European Society of Molecular Imaging, Biomarkers Society, Society of Nuclear Medicine and Molecular Imaging, International Pharmaceutical Federation, International Pharmaceutical Students Federation, Pharmaceutical Group of European Union (PGEU), Pharmaceutical Society of Australia.